Clinical Trial Update: Monotherapy-Controlled Study of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Combination in Subjects With Essential Hypertension Inadequately Controlled on Candesartan Cilexetil [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the combination of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in essential hypertension inadequately co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Nifedipine Gastrointestinal Therapeutic System (nifedipine)
• candesartan cilexetil (candesartan cilexetil)

Snippet

Sponsor: Bayer | Conditions: Hypertension | Phase 3 | Status: WITHDRAWN